Informatics in medicine unlocked · 2026
The prediction of all-cause mortality in end-stage kidney disease patients using social determinants of health: A machine learning framework.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Smith Addy, Donelan Maxwell, Rekabdarkolaee Hossein Moradi, Brooks Patti, Varilek Brandon M, Ngorsuraches Surachat, Schrier Jerry, Dell Adam, Michael Semhar
Аннотация
End-stage kidney disease (ESKD) is the irreversible final stage of chronic kidney disease in which the kidneys lose their independent function. This study presents a machine learning framework to predict all-cause mortality in ESKD patients by the end of a follow-up period. We combined patient-specific clinical factors with social determinants of health (SDOH) to assess their influence on survival outcomes. Data were obtained from the United States Renal Data System, including patients admitted in 2015 and followed through August 2021. Community-level SDOH data were integrated from the Agency for Healthcare Research and Quality, with variable screening techniques and expert input guiding feature selection. To address class imbalance, the synthetic minority oversampling technique (SMOTE) was applied. Three machine learning models were developed: logistic regression, random forest, and extreme gradient boosting. Model performance was assessed using accuracy, sensitivity, specificity, and area under the receiver operating characteristic curve (AUC). Model calibration was assessed using a calibration curve and a Brier score. The extreme gradient boosting model performed best, with an AUC of 0.7947, although other models showed comparable results. Including community-level SDOH features did not significantly improve model performance overall or within subpopulations. This suggests patient-level variables are the primary drivers of mortality prediction in ESKD. Furthermore, SMOTE did not enhance model performance in subpopulations.